Hi. I am planning a screening study for apt1a3 gene in a family with clinical manifestations. The protein is about 1013 amino acids long, so its coding part is 3042 nucleotides. Numerous mutations have been reported in its coding sequences. It seems that designing ~5 -6 pairs of primers for Sanger sequencing of cDNA might be a cost effective alternate to WES. I am not a pathologist, so need an expert advice whether or not different mutations affect mRNA synthesis and its level. Can the mutant forms be expected to express sufficiently high for capturing mutations using mRNA and cDNA, or we will be compromising on the quality of our findings by avoiding WES? Thanks.

More Ibrar Ahmed's questions See All
Similar questions and discussions